|
Volumn 17, Issue 22, 2003, Pages 38-42
|
Benchmarking best practice in relapse management of multiple sclerosis.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
STEROID;
ARTICLE;
DRUG MONITORING;
EVIDENCE BASED MEDICINE;
HUMAN;
METHODOLOGY;
MULTIPLE SCLEROSIS;
NURSE;
NURSE ATTITUDE;
NURSING;
PATIENT EDUCATION;
QUALITY CONTROL;
RECURRENT DISEASE;
SAFETY;
STANDARD;
UNITED KINGDOM;
ANTI-INFLAMMATORY AGENTS;
BENCHMARKING;
DRUG MONITORING;
ENGLAND;
EVIDENCE-BASED MEDICINE;
HUMANS;
MULTIPLE SCLEROSIS;
NURSE CLINICIANS;
NURSE'S ROLE;
NURSING AUDIT;
PATIENT EDUCATION;
RECURRENCE;
SAFETY;
STEROIDS;
|
EID: 0037433184
PISSN: 00296570
EISSN: None
Source Type: Journal
DOI: 10.7748/ns.17.22.38.s55 Document Type: Article |
Times cited : (2)
|
References (0)
|